ARTICLE | Distillery Therapeutics
Cancer
January 23, 2018 9:13 PM UTC
In vitro, cell culture and mouse studies identified a peptide-based inhibitor of the MYB-CREBBP interaction that could help treat AML. The inhibitor consisted of a retro-inverso form of a MYB fragment...
BCIQ Company Profiles